Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10113
Title: Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.
Authors: Roberts, Matthew A;Thomas, Merlin C;Fernando, Dharsh;Macmillan, Neil;Power, David Anthony;Ierino, Francesco L
Affiliation: Department of Nephrology, Austin Health, Heidelberg 3084, Victoria, Australia.
Issue Date: 6-Mar-2006
Citation: Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 2006; 21(6): 1611-7
Abstract: Advanced glycation end products (AGEs) have biological properties that may contribute to the premature cardiovascular mortality of haemodialysis patients. This study examines the hypothesis that low molecular weight forms of fluorescent AGEs (LMW fluorescence) predict mortality in haemodialysis patients.The LMW fluorescence was measured in 85 patients treated with chronic haemodialysis and prospectively followed for 4 years. The primary outcome of all-cause mortality was assessed using Cox proportional hazards regression model.At the end of the follow-up period 37 (44%) patients died. The median LMW fluorescence level was 24.2 arbitrary units (range: 10.6-148.1 AU) and the receiver operator characteristic (ROC) curve cut-off for mortality was 37.0 AU. The LMW fluorescence predicted death both as a binary variable at the ROC cut-off, and as a continuous log-transformed variable when adjusted for age, albumin and C-reactive protein (CRP). Adjusted for age, albumin and CRP, the hazard ratio for mortality was 3.05 (1.41-6.60, P = 0.005) for LMW fluorescence as a binary variable and 2.71 per log unit (1.37-5.38, P = 0.004) as a continuous log-transformed variable.The low molecular weight forms of AGEs predict mortality in patients receiving chronic haemodialysis, and may be important in the mechanisms leading to atherosclerosis and inflammation in such patients.
Internal ID Number: 16520354
URI: http://ahro.austin.org.au/austinjspui/handle/1/10113
DOI: 10.1093/ndt/gfl053
URL: http://www.ncbi.nlm.nih.gov/pubmed/16520354
Type: Journal Article
Subjects: Aged
Cardiovascular Diseases.diagnosis.etiology
Female
Fluorescence
Glycosylation End Products, Advanced.blood
Humans
Kidney Failure, Chronic.diagnosis.mortality
Male
Middle Aged
Molecular Weight
Mortality
Predictive Value of Tests
Prospective Studies
ROC Curve
Renal Dialysis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.